Immune Responses to Human Respiratory Coronaviruses Infection in Mouse Models

Overview

Journal Curr Opin Virol

Publisher Elsevier

Specialty Microbiology

Date 2021 Dec 15

PMID 34906757

Citations 5

Authors

Zhen Zhuang

Donglan Liu

Jing Sun

Fang Li

Jincun Zhao

Affiliations

Soon will be listed here.

Abstract

Human respiratory coronaviruses (HCoVs), including the recently emerged SARS-CoV-2, the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, potentially cause severe lung infections and multiple organ damages, emphasizing the urgent need for antiviral therapeutics and vaccines against HCoVs. Small animal models, especially mice, are ideal tools for deciphering the pathogenesis of HCoV infections as well as virus-induced immune responses, which is critical for antiviral drug development and vaccine design. In this review, we focus on the antiviral innate immune response, antibody response and T cell response in HCoV infected mouse models, and discuss the potential implications for understanding the anti-HCoV immunity and fighting the COVID-19 pandemic.

Citing Articles

COVID-AMD database for coronavirus-infected animal models with comparative analysis tools.

Wu Y, Li L, Wang K, Zhang Y, Wang J, Feng T Sci Rep. 2024; 14(1):29567.

PMID: 39609461 PMC: 11605124. DOI: 10.1038/s41598-024-80474-3.

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms.

Brown B, Ojha V, Fricke I, Al-Sheboul S, Imarogbe C, Gravier T Vaccines (Basel). 2023; 11(2).

PMID: 36851285 PMC: 9962967. DOI: 10.3390/vaccines11020408.

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization.

Bertoletti A, Bert N, Tan A Int J Mol Sci. 2022; 23(18).

PMID: 36142588 PMC: 9505719. DOI: 10.3390/ijms231810679.

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic.

Bertoletti A, Bert N, Tan A Immunity. 2022; 55(10):1764-1778.

PMID: 36049482 PMC: 9385766. DOI: 10.1016/j.immuni.2022.08.008.

Editorial overview: Viral pathogenesis.

Bertoletti A, Iannacone M Curr Opin Virol. 2022; 55:101253.

PMID: 35810670 PMC: 9263199. DOI: 10.1016/j.coviro.2022.101253.

References

Jia W, Channappanavar R, Zhang C, Li M, Zhou H, Zhang S . Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerg Microbes Infect. 2019; 8(1):760-772. PMC: 6542157. DOI: 10.1080/22221751.2019.1620083. View

Wu L, Wang N, Chang Y, Tian X, Na D, Zhang L . Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2008; 13(10):1562-4. PMC: 2851497. DOI: 10.3201/eid1310.070576. View

Zhao J, Zhao J, Perlman S . T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol. 2010; 84(18):9318-25. PMC: 2937604. DOI: 10.1128/JVI.01049-10. View

Pene F, Merlat A, Vabret A, Rozenberg F, Buzyn A, Dreyfus F . Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis. 2003; 37(7):929-32. PMC: 7107892. DOI: 10.1086/377612. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Lee S, Channappanavar R, Kanneganti T . Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines. Trends Immunol. 2020; 41(12):1083-1099. PMC: 7561287. DOI: 10.1016/j.it.2020.10.005. View

Channappanavar R, Fehr A, Zheng J, Wohlford-Lenane C, Abrahante J, Mack M . IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019; 129(9):3625-3639. PMC: 6715373. DOI: 10.1172/JCI126363. View

Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J . Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005; 171(8):850-7. DOI: 10.1164/rccm.200407-857OC. View

Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

10.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

11.

Rathnasinghe R, Strohmeier S, Amanat F, Gillespie V, Krammer F, Garcia-Sastre A . Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect. 2020; 9(1):2433-2445. PMC: 7655046. DOI: 10.1080/22221751.2020.1838955. View

12.

Kumar H, Kawai T, Akira S . Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. DOI: 10.3109/08830185.2010.529976. View

13.

Zhao G, Jiang Y, Qiu H, Gao T, Zeng Y, Guo Y . Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus. PLoS One. 2015; 10(12):e0145561. PMC: 4689477. DOI: 10.1371/journal.pone.0145561. View

14.

Gil-Cruz C, Perez-Shibayama C, Firner S, Waisman A, Bechmann I, Thiel V . T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease. Proc Natl Acad Sci U S A. 2012; 109(4):1233-8. PMC: 3268283. DOI: 10.1073/pnas.1115154109. View

15.

Vassilara F, Spyridaki A, Pothitos G, Deliveliotou A, Papadopoulos A . A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis. 2018; 2018:6796839. PMC: 5925015. DOI: 10.1155/2018/6796839. View

16.

Channappanavar R, Fehr A, Vijay R, Mack M, Zhao J, Meyerholz D . Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2):181-93. PMC: 4752723. DOI: 10.1016/j.chom.2016.01.007. View

17.

Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B . Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020; 130(10):5235-5244. PMC: 7524490. DOI: 10.1172/JCI138759. View

18.

Leist S, Dinnon 3rd K, Schafer A, Tse L, Okuda K, Hou Y . A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 2020; 183(4):1070-1085.e12. PMC: 7510428. DOI: 10.1016/j.cell.2020.09.050. View

19.

Jin H, Xiao C, Chen Z, Kang Y, Ma Y, Zhu K . Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun. 2005; 328(4):979-86. PMC: 7092846. DOI: 10.1016/j.bbrc.2005.01.048. View

20.

Iwata-Yoshikawa N, Okamura T, Shimizu Y, Kotani O, Sato H, Sekimukai H . Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus. J Virol. 2019; 93(6). PMC: 6401458. DOI: 10.1128/JVI.01818-18. View